Tower Research Capital LLC (TRC) - CLEMENTIA PHARMACEUTICALS IN ownership

CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 27 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CLEMENTIA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$30,000
-9.1%
1,165
-58.3%
0.00%0.0%
Q4 2018$33,000
+560.0%
2,797
+505.4%
0.00%
Q3 2018$5,000
-79.2%
462
-74.6%
0.00%
-100.0%
Q2 2018$24,000
-25.0%
1,819
-14.4%
0.00%
-66.7%
Q1 2018$32,000
+966.7%
2,124
+962.0%
0.00%
Q3 2017$3,0002000.00%
Other shareholders
CLEMENTIA PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Orbimed Advisors 10,425,225$197,871,0002.50%
NEA Management Company, LLC 2,141,697$40,649,0001.68%
RA Capital Management 585,403$11,111,0000.93%
DRIEHAUS CAPITAL MANAGEMENT LLC 862,279$16,366,0000.62%
DAFNA Capital Management LLC 60,000$1,139,0000.61%
EcoR1 Capital, LLC 194,166$3,685,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 163,000$3,094,0000.36%
Rock Springs Capital Management LP 345,000$6,548,0000.30%
Birchview Capital, LP 22,000$418,0000.24%
SECTORAL ASSET MANAGEMENT INC 75,313$1,429,0000.18%
View complete list of CLEMENTIA PHARMACEUTICALS IN shareholders